Global CRISPR/Cas9 Market Growth (Status and Outlook) 2022-2028
![](/report_cover/10189/global-crisprcas9-market-growth-status-n-outlook-2018-2023_en.gif)
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of CRISPR/Cas9 will have significant change from previous year. According to our (LP Information) latest study, the global CRISPR/Cas9 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CRISPR/Cas9 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States CRISPR/Cas9 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CRISPR/Cas9 market, reaching US$ million by the year 2028. As for the Europe CRISPR/Cas9 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CRISPR/Cas9 players cover Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR/Cas9 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of CRISPR/Cas9 will have significant change from previous year. According to our (LP Information) latest study, the global CRISPR/Cas9 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global CRISPR/Cas9 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States CRISPR/Cas9 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CRISPR/Cas9 market, reaching US$ million by the year 2028. As for the Europe CRISPR/Cas9 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CRISPR/Cas9 players cover Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR/Cas9 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Genome Editing
- Genetic Engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Caribou Biosciences
- Integrated DNA Technologies(IDT)
- CRISPR Therapeutics
- Merck
- Mirus Bio
- Editas Medicine
- Takara Bio
- Thermo Fisher Scientific
- Horizon Discovery Group
- Intellia Therapeutics
- Agilent Technologies
- Cellecta
- GenScript
- GeneCopoeia
- Synthego
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CRISPR/Cas9 Market Size 2017-2028
2.1.2 CRISPR/Cas9 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRISPR/Cas9 Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic Engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR/Cas9 Market Size by Type
2.3.1 CRISPR/Cas9 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
2.4 CRISPR/Cas9 Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR/Cas9 Market Size by Application
2.5.1 CRISPR/Cas9 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
3 CRISPR/CAS9 MARKET SIZE BY PLAYER
3.1 CRISPR/Cas9 Market Size Market Share by Players
3.1.1 Global CRISPR/Cas9 Revenue by Players (2020-2022)
3.1.2 Global CRISPR/Cas9 Revenue Market Share by Players (2020-2022)
3.2 Global CRISPR/Cas9 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR/CAS9 BY REGIONS
4.1 CRISPR/Cas9 Market Size by Regions (2017-2022)
4.2 Americas CRISPR/Cas9 Market Size Growth (2017-2022)
4.3 APAC CRISPR/Cas9 Market Size Growth (2017-2022)
4.4 Europe CRISPR/Cas9 Market Size Growth (2017-2022)
4.5 Middle East & Africa CRISPR/Cas9 Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas CRISPR/Cas9 Market Size by Country (2017-2022)
5.2 Americas CRISPR/Cas9 Market Size by Type (2017-2022)
5.3 Americas CRISPR/Cas9 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR/Cas9 Market Size by Region (2017-2022)
6.2 APAC CRISPR/Cas9 Market Size by Type (2017-2022)
6.3 APAC CRISPR/Cas9 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CRISPR/Cas9 by Country (2017-2022)
7.2 Europe CRISPR/Cas9 Market Size by Type (2017-2022)
7.3 Europe CRISPR/Cas9 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CRISPR/Cas9 by Region (2017-2022)
8.2 Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022)
8.3 Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CRISPR/CAS9 MARKET FORECAST
10.1 Global CRISPR/Cas9 Forecast by Regions (2023-2028)
10.1.1 Global CRISPR/Cas9 Forecast by Regions (2023-2028)
10.1.2 Americas CRISPR/Cas9 Forecast
10.1.3 APAC CRISPR/Cas9 Forecast
10.1.4 Europe CRISPR/Cas9 Forecast
10.1.5 Middle East & Africa CRISPR/Cas9 Forecast
10.2 Americas CRISPR/Cas9 Forecast by Country (2023-2028)
10.2.1 United States CRISPR/Cas9 Market Forecast
10.2.2 Canada CRISPR/Cas9 Market Forecast
10.2.3 Mexico CRISPR/Cas9 Market Forecast
10.2.4 Brazil CRISPR/Cas9 Market Forecast
10.3 APAC CRISPR/Cas9 Forecast by Region (2023-2028)
10.3.1 China CRISPR/Cas9 Market Forecast
10.3.2 Japan CRISPR/Cas9 Market Forecast
10.3.3 Korea CRISPR/Cas9 Market Forecast
10.3.4 Southeast Asia CRISPR/Cas9 Market Forecast
10.3.5 India CRISPR/Cas9 Market Forecast
10.3.6 Australia CRISPR/Cas9 Market Forecast
10.4 Europe CRISPR/Cas9 Forecast by Country (2023-2028)
10.4.1 Germany CRISPR/Cas9 Market Forecast
10.4.2 France CRISPR/Cas9 Market Forecast
10.4.3 UK CRISPR/Cas9 Market Forecast
10.4.4 Italy CRISPR/Cas9 Market Forecast
10.4.5 Russia CRISPR/Cas9 Market Forecast
10.5 Middle East & Africa CRISPR/Cas9 Forecast by Region (2023-2028)
10.5.1 Egypt CRISPR/Cas9 Market Forecast
10.5.2 South Africa CRISPR/Cas9 Market Forecast
10.5.3 Israel CRISPR/Cas9 Market Forecast
10.5.4 Turkey CRISPR/Cas9 Market Forecast
10.5.5 GCC Countries CRISPR/Cas9 Market Forecast
10.6 Global CRISPR/Cas9 Forecast by Type (2023-2028)
10.7 Global CRISPR/Cas9 Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Information
11.1.2 Caribou Biosciences CRISPR/Cas9 Product Offered
11.1.3 Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Caribou Biosciences Main Business Overview
11.1.5 Caribou Biosciences Latest Developments
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Information
11.2.2 Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Offered
11.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Integrated DNA Technologies(IDT) Main Business Overview
11.2.5 Integrated DNA Technologies(IDT) Latest Developments
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Information
11.3.2 CRISPR Therapeutics CRISPR/Cas9 Product Offered
11.3.3 CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 CRISPR Therapeutics Main Business Overview
11.3.5 CRISPR Therapeutics Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck CRISPR/Cas9 Product Offered
11.4.3 Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Mirus Bio
11.5.1 Mirus Bio Company Information
11.5.2 Mirus Bio CRISPR/Cas9 Product Offered
11.5.3 Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Mirus Bio Main Business Overview
11.5.5 Mirus Bio Latest Developments
11.6 Editas Medicine
11.6.1 Editas Medicine Company Information
11.6.2 Editas Medicine CRISPR/Cas9 Product Offered
11.6.3 Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Editas Medicine Main Business Overview
11.6.5 Editas Medicine Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio CRISPR/Cas9 Product Offered
11.7.3 Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific CRISPR/Cas9 Product Offered
11.8.3 Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Information
11.9.2 Horizon Discovery Group CRISPR/Cas9 Product Offered
11.9.3 Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Horizon Discovery Group Main Business Overview
11.9.5 Horizon Discovery Group Latest Developments
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Information
11.10.2 Intellia Therapeutics CRISPR/Cas9 Product Offered
11.10.3 Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Intellia Therapeutics Main Business Overview
11.10.5 Intellia Therapeutics Latest Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Information
11.11.2 Agilent Technologies CRISPR/Cas9 Product Offered
11.11.3 Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Agilent Technologies Main Business Overview
11.11.5 Agilent Technologies Latest Developments
11.12 Cellecta
11.12.1 Cellecta Company Information
11.12.2 Cellecta CRISPR/Cas9 Product Offered
11.12.3 Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Cellecta Main Business Overview
11.12.5 Cellecta Latest Developments
11.13 GenScript
11.13.1 GenScript Company Information
11.13.2 GenScript CRISPR/Cas9 Product Offered
11.13.3 GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 GenScript Main Business Overview
11.13.5 GenScript Latest Developments
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Information
11.14.2 GeneCopoeia CRISPR/Cas9 Product Offered
11.14.3 GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 GeneCopoeia Main Business Overview
11.14.5 GeneCopoeia Latest Developments
11.15 Synthego
11.15.1 Synthego Company Information
11.15.2 Synthego CRISPR/Cas9 Product Offered
11.15.3 Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Synthego Main Business Overview
11.15.5 Synthego Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CRISPR/Cas9 Market Size 2017-2028
2.1.2 CRISPR/Cas9 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRISPR/Cas9 Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic Engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR/Cas9 Market Size by Type
2.3.1 CRISPR/Cas9 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
2.4 CRISPR/Cas9 Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR/Cas9 Market Size by Application
2.5.1 CRISPR/Cas9 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
3 CRISPR/CAS9 MARKET SIZE BY PLAYER
3.1 CRISPR/Cas9 Market Size Market Share by Players
3.1.1 Global CRISPR/Cas9 Revenue by Players (2020-2022)
3.1.2 Global CRISPR/Cas9 Revenue Market Share by Players (2020-2022)
3.2 Global CRISPR/Cas9 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR/CAS9 BY REGIONS
4.1 CRISPR/Cas9 Market Size by Regions (2017-2022)
4.2 Americas CRISPR/Cas9 Market Size Growth (2017-2022)
4.3 APAC CRISPR/Cas9 Market Size Growth (2017-2022)
4.4 Europe CRISPR/Cas9 Market Size Growth (2017-2022)
4.5 Middle East & Africa CRISPR/Cas9 Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas CRISPR/Cas9 Market Size by Country (2017-2022)
5.2 Americas CRISPR/Cas9 Market Size by Type (2017-2022)
5.3 Americas CRISPR/Cas9 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR/Cas9 Market Size by Region (2017-2022)
6.2 APAC CRISPR/Cas9 Market Size by Type (2017-2022)
6.3 APAC CRISPR/Cas9 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CRISPR/Cas9 by Country (2017-2022)
7.2 Europe CRISPR/Cas9 Market Size by Type (2017-2022)
7.3 Europe CRISPR/Cas9 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CRISPR/Cas9 by Region (2017-2022)
8.2 Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022)
8.3 Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CRISPR/CAS9 MARKET FORECAST
10.1 Global CRISPR/Cas9 Forecast by Regions (2023-2028)
10.1.1 Global CRISPR/Cas9 Forecast by Regions (2023-2028)
10.1.2 Americas CRISPR/Cas9 Forecast
10.1.3 APAC CRISPR/Cas9 Forecast
10.1.4 Europe CRISPR/Cas9 Forecast
10.1.5 Middle East & Africa CRISPR/Cas9 Forecast
10.2 Americas CRISPR/Cas9 Forecast by Country (2023-2028)
10.2.1 United States CRISPR/Cas9 Market Forecast
10.2.2 Canada CRISPR/Cas9 Market Forecast
10.2.3 Mexico CRISPR/Cas9 Market Forecast
10.2.4 Brazil CRISPR/Cas9 Market Forecast
10.3 APAC CRISPR/Cas9 Forecast by Region (2023-2028)
10.3.1 China CRISPR/Cas9 Market Forecast
10.3.2 Japan CRISPR/Cas9 Market Forecast
10.3.3 Korea CRISPR/Cas9 Market Forecast
10.3.4 Southeast Asia CRISPR/Cas9 Market Forecast
10.3.5 India CRISPR/Cas9 Market Forecast
10.3.6 Australia CRISPR/Cas9 Market Forecast
10.4 Europe CRISPR/Cas9 Forecast by Country (2023-2028)
10.4.1 Germany CRISPR/Cas9 Market Forecast
10.4.2 France CRISPR/Cas9 Market Forecast
10.4.3 UK CRISPR/Cas9 Market Forecast
10.4.4 Italy CRISPR/Cas9 Market Forecast
10.4.5 Russia CRISPR/Cas9 Market Forecast
10.5 Middle East & Africa CRISPR/Cas9 Forecast by Region (2023-2028)
10.5.1 Egypt CRISPR/Cas9 Market Forecast
10.5.2 South Africa CRISPR/Cas9 Market Forecast
10.5.3 Israel CRISPR/Cas9 Market Forecast
10.5.4 Turkey CRISPR/Cas9 Market Forecast
10.5.5 GCC Countries CRISPR/Cas9 Market Forecast
10.6 Global CRISPR/Cas9 Forecast by Type (2023-2028)
10.7 Global CRISPR/Cas9 Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Caribou Biosciences
11.1.1 Caribou Biosciences Company Information
11.1.2 Caribou Biosciences CRISPR/Cas9 Product Offered
11.1.3 Caribou Biosciences CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Caribou Biosciences Main Business Overview
11.1.5 Caribou Biosciences Latest Developments
11.2 Integrated DNA Technologies(IDT)
11.2.1 Integrated DNA Technologies(IDT) Company Information
11.2.2 Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Offered
11.2.3 Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Integrated DNA Technologies(IDT) Main Business Overview
11.2.5 Integrated DNA Technologies(IDT) Latest Developments
11.3 CRISPR Therapeutics
11.3.1 CRISPR Therapeutics Company Information
11.3.2 CRISPR Therapeutics CRISPR/Cas9 Product Offered
11.3.3 CRISPR Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 CRISPR Therapeutics Main Business Overview
11.3.5 CRISPR Therapeutics Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck CRISPR/Cas9 Product Offered
11.4.3 Merck CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Mirus Bio
11.5.1 Mirus Bio Company Information
11.5.2 Mirus Bio CRISPR/Cas9 Product Offered
11.5.3 Mirus Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Mirus Bio Main Business Overview
11.5.5 Mirus Bio Latest Developments
11.6 Editas Medicine
11.6.1 Editas Medicine Company Information
11.6.2 Editas Medicine CRISPR/Cas9 Product Offered
11.6.3 Editas Medicine CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Editas Medicine Main Business Overview
11.6.5 Editas Medicine Latest Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Information
11.7.2 Takara Bio CRISPR/Cas9 Product Offered
11.7.3 Takara Bio CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Takara Bio Main Business Overview
11.7.5 Takara Bio Latest Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Information
11.8.2 Thermo Fisher Scientific CRISPR/Cas9 Product Offered
11.8.3 Thermo Fisher Scientific CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Thermo Fisher Scientific Main Business Overview
11.8.5 Thermo Fisher Scientific Latest Developments
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Information
11.9.2 Horizon Discovery Group CRISPR/Cas9 Product Offered
11.9.3 Horizon Discovery Group CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Horizon Discovery Group Main Business Overview
11.9.5 Horizon Discovery Group Latest Developments
11.10 Intellia Therapeutics
11.10.1 Intellia Therapeutics Company Information
11.10.2 Intellia Therapeutics CRISPR/Cas9 Product Offered
11.10.3 Intellia Therapeutics CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Intellia Therapeutics Main Business Overview
11.10.5 Intellia Therapeutics Latest Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Information
11.11.2 Agilent Technologies CRISPR/Cas9 Product Offered
11.11.3 Agilent Technologies CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Agilent Technologies Main Business Overview
11.11.5 Agilent Technologies Latest Developments
11.12 Cellecta
11.12.1 Cellecta Company Information
11.12.2 Cellecta CRISPR/Cas9 Product Offered
11.12.3 Cellecta CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Cellecta Main Business Overview
11.12.5 Cellecta Latest Developments
11.13 GenScript
11.13.1 GenScript Company Information
11.13.2 GenScript CRISPR/Cas9 Product Offered
11.13.3 GenScript CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 GenScript Main Business Overview
11.13.5 GenScript Latest Developments
11.14 GeneCopoeia
11.14.1 GeneCopoeia Company Information
11.14.2 GeneCopoeia CRISPR/Cas9 Product Offered
11.14.3 GeneCopoeia CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 GeneCopoeia Main Business Overview
11.14.5 GeneCopoeia Latest Developments
11.15 Synthego
11.15.1 Synthego Company Information
11.15.2 Synthego CRISPR/Cas9 Product Offered
11.15.3 Synthego CRISPR/Cas9 Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Synthego Main Business Overview
11.15.5 Synthego Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CRISPR/Cas9 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Genome Editing
Table 3. Major Players of Genetic Engineering
Table 4. Major Players of gRNA Database/Gene Librar
Table 5. Major Players of CRISPR Plasmid
Table 6. Major Players of Human Stem Cells
Table 7. Major Players of Genetically Modified Organisms/Crops
Table 8. Major Players of Cell Line Engineering
Table 9. CRISPR/Cas9 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 12. CRISPR/Cas9 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 15. Global CRISPR/Cas9 Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global CRISPR/Cas9 Revenue Market Share by Player (2020-2022)
Table 17. CRISPR/Cas9 Key Players Head office and Products Offered
Table 18. CRISPR/Cas9 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global CRISPR/Cas9 Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global CRISPR/Cas9 Market Size Market Share by Regions (2017-2022)
Table 23. Americas CRISPR/Cas9 Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas CRISPR/Cas9 Market Size Market Share by Country (2017-2022)
Table 25. Americas CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 27. Americas CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 29. APAC CRISPR/Cas9 Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC CRISPR/Cas9 Market Size Market Share by Region (2017-2022)
Table 31. APAC CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 33. APAC CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 35. Europe CRISPR/Cas9 Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe CRISPR/Cas9 Market Size Market Share by Country (2017-2022)
Table 37. Europe CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 39. Europe CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa CRISPR/Cas9 Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of CRISPR/Cas9
Table 48. Key Market Challenges & Risks of CRISPR/Cas9
Table 49. Key Industry Trends of CRISPR/Cas9
Table 50. Global CRISPR/Cas9 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global CRISPR/Cas9 Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global CRISPR/Cas9 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global CRISPR/Cas9 Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global CRISPR/Cas9 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global CRISPR/Cas9 Market Size Market Share Forecast by Application (2023-2028)
Table 56. Caribou Biosciences Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 57. Caribou Biosciences CRISPR/Cas9 Product Offered
Table 58. Caribou Biosciences CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Caribou Biosciences Main Business
Table 60. Caribou Biosciences Latest Developments
Table 61. Integrated DNA Technologies(IDT) Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 62. Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Offered
Table 63. Integrated DNA Technologies(IDT) Main Business
Table 64. Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Integrated DNA Technologies(IDT) Latest Developments
Table 66. CRISPR Therapeutics Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 67. CRISPR Therapeutics CRISPR/Cas9 Product Offered
Table 68. CRISPR Therapeutics Main Business
Table 69. CRISPR Therapeutics CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. CRISPR Therapeutics Latest Developments
Table 71. Merck Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 72. Merck CRISPR/Cas9 Product Offered
Table 73. Merck Main Business
Table 74. Merck CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Merck Latest Developments
Table 76. Mirus Bio Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 77. Mirus Bio CRISPR/Cas9 Product Offered
Table 78. Mirus Bio Main Business
Table 79. Mirus Bio CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Mirus Bio Latest Developments
Table 81. Editas Medicine Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 82. Editas Medicine CRISPR/Cas9 Product Offered
Table 83. Editas Medicine Main Business
Table 84. Editas Medicine CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Editas Medicine Latest Developments
Table 86. Takara Bio Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 87. Takara Bio CRISPR/Cas9 Product Offered
Table 88. Takara Bio Main Business
Table 89. Takara Bio CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Takara Bio Latest Developments
Table 91. Thermo Fisher Scientific Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 92. Thermo Fisher Scientific CRISPR/Cas9 Product Offered
Table 93. Thermo Fisher Scientific Main Business
Table 94. Thermo Fisher Scientific CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Thermo Fisher Scientific Latest Developments
Table 96. Horizon Discovery Group Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 97. Horizon Discovery Group CRISPR/Cas9 Product Offered
Table 98. Horizon Discovery Group Main Business
Table 99. Horizon Discovery Group CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Horizon Discovery Group Latest Developments
Table 101. Intellia Therapeutics Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 102. Intellia Therapeutics CRISPR/Cas9 Product Offered
Table 103. Intellia Therapeutics Main Business
Table 104. Intellia Therapeutics CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Intellia Therapeutics Latest Developments
Table 106. Agilent Technologies Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 107. Agilent Technologies CRISPR/Cas9 Product Offered
Table 108. Agilent Technologies CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Agilent Technologies Main Business
Table 110. Agilent Technologies Latest Developments
Table 111. Cellecta Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 112. Cellecta CRISPR/Cas9 Product Offered
Table 113. Cellecta Main Business
Table 114. Cellecta CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cellecta Latest Developments
Table 116. GenScript Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 117. GenScript CRISPR/Cas9 Product Offered
Table 118. GenScript Main Business
Table 119. GenScript CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. GenScript Latest Developments
Table 121. GeneCopoeia Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 122. GeneCopoeia CRISPR/Cas9 Product Offered
Table 123. GeneCopoeia Main Business
Table 124. GeneCopoeia CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. GeneCopoeia Latest Developments
Table 126. Synthego Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 127. Synthego CRISPR/Cas9 Product Offered
Table 128. Synthego Main Business
Table 129. Synthego CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Synthego Latest Developments
Table 1. CRISPR/Cas9 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Genome Editing
Table 3. Major Players of Genetic Engineering
Table 4. Major Players of gRNA Database/Gene Librar
Table 5. Major Players of CRISPR Plasmid
Table 6. Major Players of Human Stem Cells
Table 7. Major Players of Genetically Modified Organisms/Crops
Table 8. Major Players of Cell Line Engineering
Table 9. CRISPR/Cas9 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 12. CRISPR/Cas9 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 15. Global CRISPR/Cas9 Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global CRISPR/Cas9 Revenue Market Share by Player (2020-2022)
Table 17. CRISPR/Cas9 Key Players Head office and Products Offered
Table 18. CRISPR/Cas9 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global CRISPR/Cas9 Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global CRISPR/Cas9 Market Size Market Share by Regions (2017-2022)
Table 23. Americas CRISPR/Cas9 Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas CRISPR/Cas9 Market Size Market Share by Country (2017-2022)
Table 25. Americas CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 27. Americas CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 29. APAC CRISPR/Cas9 Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC CRISPR/Cas9 Market Size Market Share by Region (2017-2022)
Table 31. APAC CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 33. APAC CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 35. Europe CRISPR/Cas9 Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe CRISPR/Cas9 Market Size Market Share by Country (2017-2022)
Table 37. Europe CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 39. Europe CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa CRISPR/Cas9 Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa CRISPR/Cas9 Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa CRISPR/Cas9 Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of CRISPR/Cas9
Table 48. Key Market Challenges & Risks of CRISPR/Cas9
Table 49. Key Industry Trends of CRISPR/Cas9
Table 50. Global CRISPR/Cas9 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global CRISPR/Cas9 Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global CRISPR/Cas9 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global CRISPR/Cas9 Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global CRISPR/Cas9 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global CRISPR/Cas9 Market Size Market Share Forecast by Application (2023-2028)
Table 56. Caribou Biosciences Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 57. Caribou Biosciences CRISPR/Cas9 Product Offered
Table 58. Caribou Biosciences CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Caribou Biosciences Main Business
Table 60. Caribou Biosciences Latest Developments
Table 61. Integrated DNA Technologies(IDT) Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 62. Integrated DNA Technologies(IDT) CRISPR/Cas9 Product Offered
Table 63. Integrated DNA Technologies(IDT) Main Business
Table 64. Integrated DNA Technologies(IDT) CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Integrated DNA Technologies(IDT) Latest Developments
Table 66. CRISPR Therapeutics Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 67. CRISPR Therapeutics CRISPR/Cas9 Product Offered
Table 68. CRISPR Therapeutics Main Business
Table 69. CRISPR Therapeutics CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. CRISPR Therapeutics Latest Developments
Table 71. Merck Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 72. Merck CRISPR/Cas9 Product Offered
Table 73. Merck Main Business
Table 74. Merck CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Merck Latest Developments
Table 76. Mirus Bio Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 77. Mirus Bio CRISPR/Cas9 Product Offered
Table 78. Mirus Bio Main Business
Table 79. Mirus Bio CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Mirus Bio Latest Developments
Table 81. Editas Medicine Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 82. Editas Medicine CRISPR/Cas9 Product Offered
Table 83. Editas Medicine Main Business
Table 84. Editas Medicine CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Editas Medicine Latest Developments
Table 86. Takara Bio Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 87. Takara Bio CRISPR/Cas9 Product Offered
Table 88. Takara Bio Main Business
Table 89. Takara Bio CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Takara Bio Latest Developments
Table 91. Thermo Fisher Scientific Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 92. Thermo Fisher Scientific CRISPR/Cas9 Product Offered
Table 93. Thermo Fisher Scientific Main Business
Table 94. Thermo Fisher Scientific CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Thermo Fisher Scientific Latest Developments
Table 96. Horizon Discovery Group Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 97. Horizon Discovery Group CRISPR/Cas9 Product Offered
Table 98. Horizon Discovery Group Main Business
Table 99. Horizon Discovery Group CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Horizon Discovery Group Latest Developments
Table 101. Intellia Therapeutics Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 102. Intellia Therapeutics CRISPR/Cas9 Product Offered
Table 103. Intellia Therapeutics Main Business
Table 104. Intellia Therapeutics CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Intellia Therapeutics Latest Developments
Table 106. Agilent Technologies Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 107. Agilent Technologies CRISPR/Cas9 Product Offered
Table 108. Agilent Technologies CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Agilent Technologies Main Business
Table 110. Agilent Technologies Latest Developments
Table 111. Cellecta Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 112. Cellecta CRISPR/Cas9 Product Offered
Table 113. Cellecta Main Business
Table 114. Cellecta CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Cellecta Latest Developments
Table 116. GenScript Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 117. GenScript CRISPR/Cas9 Product Offered
Table 118. GenScript Main Business
Table 119. GenScript CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. GenScript Latest Developments
Table 121. GeneCopoeia Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 122. GeneCopoeia CRISPR/Cas9 Product Offered
Table 123. GeneCopoeia Main Business
Table 124. GeneCopoeia CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. GeneCopoeia Latest Developments
Table 126. Synthego Details, Company Type, CRISPR/Cas9 Area Served and Its Competitors
Table 127. Synthego CRISPR/Cas9 Product Offered
Table 128. Synthego Main Business
Table 129. Synthego CRISPR/Cas9 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Synthego Latest Developments
LIST OF FIGURES
Figure 1. CRISPR/Cas9 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR/Cas9 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 7. CRISPR/Cas9 in Biotechnology Companies
Figure 8. Global CRISPR/Cas9 Market: Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. CRISPR/Cas9 in Pharmaceutical Companies
Figure 10. Global CRISPR/Cas9 Market: Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 11. CRISPR/Cas9 in Academic Institutes
Figure 12. Global CRISPR/Cas9 Market: Academic Institutes (2017-2022) & ($ Millions)
Figure 13. CRISPR/Cas9 in Research and Development Institutes
Figure 14. Global CRISPR/Cas9 Market: Research and Development Institutes (2017-2022) & ($ Millions)
Figure 15. Global CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 16. Global CRISPR/Cas9 Revenue Market Share by Player in 2021
Figure 17. Global CRISPR/Cas9 Market Size Market Share by Regions (2017-2022)
Figure 18. Americas CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 19. APAC CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 20. Europe CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 22. Americas CRISPR/Cas9 Value Market Share by Country in 2021
Figure 23. Americas CRISPR/Cas9 Consumption Market Share by Type in 2021
Figure 24. Americas CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 25. United States CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC CRISPR/Cas9 Market Size Market Share by Region in 2021
Figure 30. APAC CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 31. China CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 35. India CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe CRISPR/Cas9 Market Size Market Share by Country in 2021
Figure 38. Europe CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 39. Europe CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 40. Germany CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 41. France CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 48. Egypt CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 54. APAC CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 55. Europe CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 57. United States CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 58. Canada CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 59. Mexico CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 60. Brazil CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 61. China CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 62. Japan CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 63. Korea CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 65. India CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 66. Australia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 67. Germany CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 68. France CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 69. UK CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 70. Italy CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 71. Russia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 72. Spain CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 73. Egypt CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 74. South Africa CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 75. Israel CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 76. Turkey CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 1. CRISPR/Cas9 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR/Cas9 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 7. CRISPR/Cas9 in Biotechnology Companies
Figure 8. Global CRISPR/Cas9 Market: Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. CRISPR/Cas9 in Pharmaceutical Companies
Figure 10. Global CRISPR/Cas9 Market: Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 11. CRISPR/Cas9 in Academic Institutes
Figure 12. Global CRISPR/Cas9 Market: Academic Institutes (2017-2022) & ($ Millions)
Figure 13. CRISPR/Cas9 in Research and Development Institutes
Figure 14. Global CRISPR/Cas9 Market: Research and Development Institutes (2017-2022) & ($ Millions)
Figure 15. Global CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 16. Global CRISPR/Cas9 Revenue Market Share by Player in 2021
Figure 17. Global CRISPR/Cas9 Market Size Market Share by Regions (2017-2022)
Figure 18. Americas CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 19. APAC CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 20. Europe CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa CRISPR/Cas9 Market Size 2017-2022 ($ Millions)
Figure 22. Americas CRISPR/Cas9 Value Market Share by Country in 2021
Figure 23. Americas CRISPR/Cas9 Consumption Market Share by Type in 2021
Figure 24. Americas CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 25. United States CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC CRISPR/Cas9 Market Size Market Share by Region in 2021
Figure 30. APAC CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 31. China CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 35. India CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe CRISPR/Cas9 Market Size Market Share by Country in 2021
Figure 38. Europe CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 39. Europe CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 40. Germany CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 41. France CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa CRISPR/Cas9 Market Size Market Share by Application in 2021
Figure 48. Egypt CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country CRISPR/Cas9 Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 54. APAC CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 55. Europe CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 57. United States CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 58. Canada CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 59. Mexico CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 60. Brazil CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 61. China CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 62. Japan CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 63. Korea CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 65. India CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 66. Australia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 67. Germany CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 68. France CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 69. UK CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 70. Italy CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 71. Russia CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 72. Spain CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 73. Egypt CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 74. South Africa CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 75. Israel CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 76. Turkey CRISPR/Cas9 Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries CRISPR/Cas9 Market Size 2023-2028 ($ Millions)